Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study.

Saved in:
Bibliographic Details
Title: Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in a Rapid-Initiation Model of Care for Human Immunodeficiency Virus Type 1 Infection: Primary Analysis of the DIAMOND Study.
Authors: Huhn GD; Ruth M. Rothstein CORE Center, Chicago, Illinois, USA., Crofoot G; Crofoot Research Center, Houston, Texas, USA., Ramgopal M; Midway Immunology and Research Center, Fort Pierce, Florida, USA., Gathe J; Therapeutic Concepts, Houston, Texas, USA., Bolan R; Los Angeles LGBT Center, Los Angeles, California, USA., Luo D; Janssen Research & Development, LLC, Titusville, New Jersey, USA., Simonson RB; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA., Nettles RE; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA., Benson C; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA., Dunn K; Janssen Scientific Affairs, LLC, Titusville, New Jersey, USA.
Source: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2020 Dec 15; Vol. 71 (12), pp. 3110-3117.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: United States NLM ID: 9203213 Publication Model: Print Cited Medium: Internet ISSN: 1537-6591 (Electronic) Linking ISSN: 10584838 NLM ISO Abbreviation: Clin Infect Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1537-6591
DOI:10.1093/cid/ciz1213